Statistics for Blueprint Medicines (id:7475 BPMC)

Valuation metrics

Market cap

6.02B

Enterprise value

6.01B

Trailing P/E (ttm)

-11.25

Forward P/E

-100.86

PEG ratio

-100.86

Price/Sales (ttm)

13.86

Price/Book (mrq)

19.21

Enterprise Value/Revenue

13.83

Enterprise Value/EBITDA

-22.92

Overview

Shares outstanding

63.53M

Float

62.83M

Shares short

4.13M

% Held by insiders

0.01%

% Held by institutions

1.04%

Average volume (10 days)

592.91K

Average volume (90 days)

Price summary

52-Week low

67.00

52-Week high

121.90

52-Week change

26.58%

Beta

0.59

50-Day moving average

89.67

200-Day moving average

95.71

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-29.48%

Operating margin

-38.21%

Operational effectiveness

Return on assets

-14.96%

Return on equity

-49.66%

Income statement

Revenue (ttm)

6.99

Revenue per share (ttm)

6.99

Quarterly revenue growth (yoy)

Gross profit (ttm)

240.84M

EBITDA

-262,128,992.00

Net income to common (ttm)

-128,049,000.00

Diluted EPS (ttm)

-2.09

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

734.17M

Total cash per share (mrq)

11.56

Total debt (mrq)

732.70M

Total Debt/Equity (mrq)

233.98

Current ratio (mrq)

331.80%

Book value per share (mrq)

4.94

Cash flow

Cash flow statement

-242,150,000.00

Levered free cash flow (LFCF)

-101,520,128.00